Tarsus Pharmaceuticals logo
Tarsus Pharmaceuticals TARS
$ 70.19 0.0%

Annual report 2025
added 02-23-2026

report update icon

Tarsus Pharmaceuticals P/S Ratio 2011-2026 | TARS

Annual P/S Ratio Tarsus Pharmaceuticals

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
6.47 8.44 66.9 37.9 7.93 - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
66.9 6.47 25.5

P/S Ratio of other stocks in the Biotechnology industry

Issuer P/S Ratio Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
1.75 - 2.43 % $ 254 M germanyGermany
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
131 $ 3.6 1.34 % $ 8.66 B australiaAustralia
Aytu BioScience Aytu BioScience
AYTU
0.237 $ 2.66 - $ 16.7 M usaUSA
BioNTech SE BioNTech SE
BNTX
35.7 $ 91.28 - $ 27.2 B germanyGermany
I-Mab I-Mab
IMAB
94.1 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.53 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
1.96 K - 2.54 % $ 160 B franceFrance
Burford Capital Limited Burford Capital Limited
BUR
6.35 $ 4.48 - $ 736 M britainBritain
Cerus Corporation Cerus Corporation
CERS
2.12 $ 1.85 - $ 353 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
137 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.39 K - -1.52 % $ 24.7 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
0.142 - -24.86 % $ 820 K usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
5.36 $ 1.67 - $ 196 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
1.32 K $ 31.37 - $ 2.08 B usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
10.4 $ 0.44 - $ 5.04 M israelIsrael
Advaxis Advaxis
ADXS
144 - -9.65 % $ 45.9 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
76.4 - - $ 86.2 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
2.61 - - - russiaRussia
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
5.16 $ 24.98 - $ 3.05 B usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
2.86 $ 10.14 - $ 135 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
196 $ 1.58 - $ 106 M usaUSA
Curis Curis
CRIS
1 $ 0.53 - $ 6.98 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
534 $ 37.7 - $ 3.55 B usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.25 K $ 49.15 - $ 4.42 B schweizSchweiz
Aeterna Zentaris Aeterna Zentaris
AEZS
7.87 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
0.099 - -10.17 % $ 12.2 K usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
12.2 $ 4.4 - $ 607 M usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
1.21 K $ 0.86 - $ 5.79 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
489 - - $ 1.01 B usaUSA
Cue Biopharma Cue Biopharma
CUE
1.07 $ 0.18 - $ 17.1 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
65.5 - - $ 26.5 M usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
500 $ 20.36 - $ 2.84 B franceFrance
AIkido Pharma AIkido Pharma
AIKI
0.935 - 1.93 % $ 17.4 M usaUSA
Denali Therapeutics Denali Therapeutics
DNLI
7.68 $ 19.38 - $ 3.19 B usaUSA
Dyadic International Dyadic International
DYAI
10.2 $ 0.87 -2.8 % $ 31.5 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
281 - - $ 867 M germanyGermany
Entera Bio Ltd. Entera Bio Ltd.
ENTX
83.8 $ 1.19 - $ 55.5 M israelIsrael
Equillium Equillium
EQ
1.77 $ 2.01 - $ 115 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
11 $ 330.34 - $ 43.3 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
8.94 - - $ 2.17 B usaUSA
Fate Therapeutics Fate Therapeutics
FATE
28.1 $ 1.19 - $ 141 M usaUSA